Publicacións (155)

¹ Publicaciones consideradas como producción del grupo

Ver datos de investigación referenciados.

filter_list

2025

  1. Bimolecular Fluorescence Complementation Assay to Evaluate the Interaction Between SUMO and Its Target Proteins in Cells

    Methods in molecular biology (Clifton, N.J.), Vol. 2957, pp. 207-213

  2. Cryptic mitochondrial DNA mutations coincide with mid-late life and are pathophysiologically informative in single cells across tissues and species

    Nature Communications , Vol. 16, Núm. 1

  3. Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity

    Nature Communications , Vol. 16, Núm. 1

  4. Cáncer de ovario: El poder de la terapia combinada

    Investigación: cultura, ciencia y tecnología, Núm. 34, pp. 20-30

  5. Editorial: Molecular and cellular pathways leading to mitochondrial dysfunction and neurodegeneration: lessons from in vivo models, volume II

    Frontiers in Neuroscience

  6. Global analysis by LC-MS/MS of N6-methyladenosine and inosine in mRNA reveal complex incidence

    RNA, Vol. 31, Núm. 4, pp. 514-528

  7. Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathway

    Hepatology, Vol. 81, Núm. 5, pp. 1535-1552

  8. Multiparametric super-resolution optoacoustic imaging with ICG-tagged microbubbles

    Materials Today Bio, Vol. 32

  9. Organization and development of bilateral somatosensory feedback projections in mice

    iScience, Vol. 28, Núm. 6

  10. Preface

    Methods in Molecular Biology

  11. SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation

    Cell Death and Disease, Vol. 16, Núm. 1

  12. Scalable Copper Sulfide Formulations for Super-Resolution Optoacoustic Brain Imaging in the Second Near-Infrared Window

    Small Methods, Vol. 9, Núm. 1

  13. Targeted delivery of therapeutics to metastatic lung cancer cells using aptamer-conjugated nanoemulsions

    Journal of Controlled Release, Vol. 385

  14. Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

    Molecular Oncology, Vol. 19, Núm. 10, pp. 2978-2988

  15. Therapeutic modulation of protein RBM3 for ischemic stroke treatment

    Frontiers in Pharmacology

  16. Transcriptional repression of SOX2 by p53 in cancer cells regulates cell identity and migration

    International Journal of Cancer, Vol. 157, Núm. 5, pp. 980-992